Lack of neighborhood effects from a transcriptionally active phosphoglycerate kinase-neo cassette located between the murine β-major and β-minor globin genes

Blood

Volumn 98, Issue 1, 2001, Pages 65-73

  Kaufman, Richard M ^a   Lu, Zhi Hong ^a   Behl, Rajesh ^a   Holt, Jo M ^a   Ackers, Gary K ^a   Ley, Timothy J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; DNA; HEMOGLOBIN; KANAMYCIN KINASE; RNA;

ANIMAL MODEL; ARTICLE; BLOOD SMEAR; BONE MARROW CELL; ERYTHROCYTE COUNT; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMATOPOIETIC STEM CELL; HEMOGLOBIN DETERMINATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN AFFINITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SICKLE CELL TRAIT;

EID: 0035412354     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.1.65     Document Type: Article

References (42)

1. Stamatoyannopoulos G, Nienhuis AW. Hemoglobin switching. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases. 2nd ed. Philadelphia: WB Saunders; 1994:107-155.
2. Persons DA, Nienhuis AW. Gene therapy for the hemoglobin disorders: past, present, and future. Proc Natl Acad Sci U S A. 2000;97:5022-5024.
3. + bone marrow cells. Blood. 1993;82:1975-1980.
4. Van Beusechem VM, Kukler A, Heidt PJ, Valerio D. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc Natl Acad Sci U S A. 1992;89:7640-7644.
5. McCune SL, Townes TM. Retroviral vector sequences inhibit human β-globin gene expression in transgenic mice. Nucleic Acids Res. 1994;22:4477-4481.
6. Rivella S, Sadelain M. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing, Semin Hematol. 1998;35:112-125.
7. Novak U, Harris EA, Forrester W, Groudine M, Gelinas R. High-level beta-globin expression after transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells. Proc Natl Acad Sci U S A. 1990;87:3386-3390.
8. Plavec I, Papayannopoulou T, Maury C, Meyer F, A human β-globin gene fused to the human β-globin locus control region is expressed at high levels in erythroid cells of mice engrafted with retrovirus-transduced hematopoietic stem cells. Blood. 1993;81:1384-1392.
9. Sadelain M, Wang CH, Antoniou M, Grosveld F, Mulligan RC. Generation of a high-titer retroviral vector capable of expressing high levels of the human β-globin gene. Proc Natl Acad Sci U S A. 1995;92:6728-6732,
10. May C, Rivella S, Callegari J, et al. Therapeutic haemoglobin synthesis in β-thalassemia mice expressing lentivirus-encoded human β-globin. Nature. 2000;406:82-85.
11. Cole-Strauss A, Yoon K, Xiang Y, et al. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science, 1996;273:1386-1389.
12. Lan N, Howrey RP, Lee S-W, Smith CA, Sullenger BA. Ribozyme-mediated repair of sickle β-globin mRNAs in erythrocyte precursors. Science. 1998;280:1593-1596.
13. Shesely EG, Kim H-S, Shehee WR, Papayannopoulou T, Smithies O, Popovich BW. Correction of a human βs-globin gene by gene targeting. Proc Natl Acad Sci U S A. 1991;88:4294-4298.
14. Russell DW, Hirata RK. Human gene targeting by viral vectors. Nat Genet. 1998;18:325-330,
15. Yáñez RJ, Porter ACG, Gene targeting is enhanced in human cells overexpressing bRAD51, Gene Ther. 1999;6:1282-1290.
16. Kim CG, Epner EM, Forrester WC, Groudine M. Inactivation of the human β-globin gene by targeted insertion into the β-globin locus control region. Genes Dev. 1992;6:928-938.
17. Fiering S, Kim CG, Epner EM, Groudine M. An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the β-globin locus control region. Proc Natl Acad Sci U S A. 1993;90:8469-8473.
18. Fiering S, Epner E, Robinson K, et al. Targeted deletion of 5′HS2 of the murine-β-globin LCR reveals that it is not essential for proper regulation of the β-globin locus. Genes Dev. 1995;9:2203-2213.
19. Hug BA, Wesselschmidt RL, Fiering S, et al. Analysis of mice containing a targeted deletion of β-globin locus control region 5′ hypersensitive site 3. Mol Cell Biol. 1996;16:2906-2912.
20. Olson EN, Arnold H-H, Rigby PWJ, Wold BJ. Know your neighbors: three phenotypes in null mutations of the myogenic bHLH gene MRF4. Cell. 1996;85:1-4.
21. Pham CTN, MacIvor DM, Hug BA, Heusel JW, Ley TJ. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci U S A. 1996;93:13090-12095.
22. Brown SA, Kingston RE. Disruption of down-stream chromatin directed by a transcriptional activator. Genes Dev. 1997;11:3116-3121,
23. McDevitt MA, Shivdasani RA, Fujiwara Y, Yang H, Orkin SH. A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci U S A. 1997;94:6781-6785.
24. Reik A, Telling A, Zitnik G, Cimbora D, Epner E, Groudine M. The locus control region is necessary for gene expression in the human &-globin locus but not the maintenance of an open chromatin structure in erythroid cells. Mol Cell Biol. 1998;18:5992-6000.
25. Kaufman RM, Pham CTN, Ley TJ. Transgenic analysis of a 100-kb human β-globin cluster-containing DNA fragment propagated as a bacterial artificial chromosome. Blood, 1999;94:3178-3184.
26. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: pitfalls and potential. Biotechniques. 1999;26:112-122.
27. Alter BP, Goff SC, Efremov GD, Gravely ME, Huisman THJ. Globin chain electrephoresis: a new approach to the determination of the Gg/Ag ratio in fetal haemoglobin and to studies of globin synthesis. Br J Haematol. 1980;44:527-534.
28. MacIvor DM, Pham CTN, Ley TJ. The 5'flanking region of the human granzyme H gene directs expression to T/natural killer cell progenitors and lymphokine-activated killer cells in transgenic mice. Blood. 1999;93:963-973.
29. Kim HC, Schwartz E. Sickle hemoglobin. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds. Hematology. 4th ed. New York: McGraw-Hill; 1990:1722-1723.
30. Graubert TA, Hug BA, Wesselschmidt R, et al. Stochastic, stage-specific mechanisms account for the variegation of a human globin transgene. Nucleic Acids Res. 1998;26:2849-2858.
31. Dolman D, Gill SJ. Membrane-covered thin-layer optical cell for gas-reaction studies of hemoglobin. Anal Biochem. 1978;87:127-134.
32. Doyle ML, Lew G, Turner GJ, Rucknagel D, Ackers GK. Regulation of oxygen affinity by quaternary enhancement: does hemoglobin ypsilanti represent an allosteric intermediate? Proteins. 1992;14:351-362.
33. Skow LC, Burkhart B, Johnson FM, et al. A mouse model for β-thalassemia. Cell. 1983;34:1043-1052.
34. Shehee WR, Oliver P, Smithies O. Lethal thalassemia after insertional disruption of the mouse major adult β-globin gene. Proc Natl Acad Sci U S A. 1993;90:3177-3181.
35. Schechter AN, Noguchi CT. Sickle hemoglobin polymer: structure-function correlates. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds, Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven; 1994;33-51.
36. Fabry ME, Nagel RL, Pachnis A, Suzuka SM, Costantini F. High expression of human βS- and α-globins in transgenic mice: hemoglobin composition and hematologic consequences. Proc Natl Acad Sci U S A. 1992;89:12150-12154.
37. Fabry ME, Costantini F, Pachnis A, et al. High expression of human βS- and α-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci U S A. 1992;89:12155-12159.
38. Fabry ME, Kennan RP, Pàszty C, et al. Magnetic resonance evidence of hypoxia in a homozygous a-knockout of a transgenic mouse model for sickle cell disease. J Clin Invest. 1996;98:2450-2455.
39. Ryan TM, Ciavatta DJ, Townes TM. Knockouttransgenic mouse model of sickle cell disease. Science. 1997;278:873-875.
40. Pàszty C, Brion CM, Manci E, et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 1997;278:876-878.
41. Chang JC, Lu R, Lin C, et al. Transgenic knock-out mice exclusively expressing human hemoglobin S after transfer of a 240-kb βS-globin yeast artificial chromosome: a mouse model of sickle cell anemia. Proc Natl Acad Sci U S A. 1998;95:14886-14890.
42. Hatada S, Nikkuni K, Bentley SA, Kirby S, Smithies O. Gene correction in hematopoietic progenitor cells by homologous recombination. Proc Natl Acad Sci U S A 2000;97:13807-13811.